Urology

The Department of Urology of Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine is currently a doctoral and master's degree-granting site for Integrated Chinese and Western Medicine Urologic Surgery at Shanghai University of Traditional Chinese Medicine, an institutional member of the East China Training Center of the Chinese Urological Association, a member institution of the National Urology Single-Port Laparoscopy Collaboration Group, the leading institution of the Yangtze River Delta Alliance of Urology Specialties of Traditional Chinese Medicine Hospitals, a member institution of the Shanghai Multicenter Research Alliance for Renal Cancer, a cooperating institution for Integrated Chinese and Western Medicine Andrology in Shanghai, and the leading institution of the Pudong New Area Community Workstation for Integrated Chinese and Western Medicine Diagnosis and Treatment of Prostate Diseases.

Department History:

The Department of Urology of Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine was founded in 1949 by Professor Ma Yongjiang, one of the founders of urology in New China. Since its establishment, through the joint efforts of generations including Professors Jiang Guoxiong, Huang Ankang, Cai Zhigang, and Zhao Jianhua, the department has gradually become a discipline with strong medical and technical capabilities, high standards of medical ethics and conduct, excellent traditions, and prominent advantages in the integration of Chinese and Western medicine.

Department Current Status:

Since Professor Xu Dongliang joined the department in November 2020, it has flourished under the leadership of Director Xu Dongliang, the new-generation discipline leader, and has now developed into a professionally specialized discipline integrating medical care, teaching, and scientific research that enjoys a high reputation in China. The Department of Urology adheres to a development objective focused on medical technology and medical quality, combining scientific research with clinical practice, and has formed excellent medical traditions and a rigorous academic atmosphere. The entire department is sincerely united and strives for progress; its personnel continue to work hard and constantly reach for new heights. They have developed a number of highly challenging new technologies and projects, particularly in minimally invasive urological technologies such as da Vinci robotic, single-port, and 3D laparoscopic surgery, as well as in urological tumors, stones, and comprehensive integrated Chinese and Western medicine treatment in andrology. Medical technology and academic standards have advanced by leaps and bounds and developed rapidly, reaching internationally advanced and domestically leading levels, earning high recognition from peers and praise from patients.

The department currently has a rational personnel structure and strong technical capabilities, and all personnel have postgraduate-level qualifications. There are 2 chief physicians, 7 associate chief physicians, and 4 attending physicians, as well as numerous graduate students, visiting trainees, standardized residency trainees, and others. It has 60 open beds divided between East and West campuses. It mainly consists of 6 subspecialties: urological tumors, urinary calculi and urinary tract repair and reconstruction, prostate diseases, female and pediatric urology, andrology, and integrated Chinese and Western medicine urology. It has functional units including a urology ward, outpatient clinic, andrology examination and treatment room, extracorporeal shock wave lithotripsy room, and urodynamic examination room. It possesses a wide range of high-end, cutting-edge instruments and equipment, including the latest-generation da Vinci Xi surgical robot, Olympus 3D laparoscope, thulium laser, holmium laser, plasma resectoscope, nephroscope, flexible/rigid ureteroscopes, flexible cystoscope, BK ultrasound, extracorporeal shock wave lithotripter, urodynamic testing instrument, male function testing instrument, and others.

Diagnostic and treatment services cover all diseases in urology. All types of urological and andrological surgery are routinely performed, including ① robotic and laparoscopic minimally invasive surgery: vena cava tumor thrombus removal, radical prostatectomy for prostate cancer, radical cystectomy for bladder cancer, partial nephrectomy, radical nephrectomy for renal cancer, radical surgery for renal pelvis and ureteral cancer, adrenal tumor resection, retroperitoneal tumor resection, retroperitoneal lymph node dissection for testicular cancer, inguinal lymph node dissection for penile cancer, pyeloureteroplasty, bladder-flap/intestinal ureteral replacement for ureteral stricture, and urethra-preserving prostatectomy; ② minimally invasive surgery for urinary calculi: percutaneous nephrolithotomy with lithotripsy and stone extraction, flexible/rigid ureteroscopic lithotripsy, bladder stone lithotripsy, and others; ③ transurethral minimally invasive surgery: laser/plasma prostate enucleation, transurethral laser en bloc resection of bladder tumors, urethral stricture reconstruction, and others; ④ female and pediatric urological surgery: TVT, TVT-O, pelvic floor reconstruction, sacral neuromodulation, pediatric congenital ureteral stricture reconstruction, megaureter reconstruction, nephrectomy of a nonfunctioning duplicated kidney, hypospadias repair, circumcision, reconstructive and plastic surgery for penile deformities, orchiopexy for undescended testis, and others; ⑤ andrology: surgery for Peyronie's disease, penile correction surgery, three-piece penile prosthesis implantation, seminal vesiculoscopy, high ligation of varicocele, testicular biopsy, microscopic testicular sperm extraction, and others. The department has established a model with robotic, 3D laparoscopic, single-port, and other minimally invasive surgeries as its technical core, and comprehensive integrated Chinese and Western medicine treatment and Traditional Chinese Medicine Rapid-Recovery Surgery (CM-ERAS) as its diagnostic and treatment features. It was the first in Shanghai to perform fourth-generation da Vinci robotic single-port laparoscopic surgery, including robot-assisted procedures at internationally advanced and domestically leading levels such as radical cystectomy + orthotopic ileal neobladder and radical prostatectomy for prostate cancer. It is particularly at an internationally leading level in radical cystectomy with an orthotopic neobladder, urinary continence preservation during radical prostatectomy for prostate cancer, and nephron-sparing treatment of renal tumors. It also makes full use of the advantages of traditional Chinese medicine, forming a novel combined treatment represented by modified Shenqi Dihuang Decoction together with targeted drugs, immune checkpoint inhibitors (PD-1/PD-L1 inhibitors), antibody-drug conjugates (ADC), and other adjuvant and neoadjuvant treatments, as well as rational combinations of surgery and drugs, to maximize the cure rate of urological tumors and significantly prolong patient survival and improve patients' quality of life.

In recent years, the discipline has developed comprehensively in medical care, education, and research. It closely follows the most cutting-edge trends in scientific and technological development in China and abroad, starts from actual clinical needs, takes clinical problems as its guide, and focuses its research on the early diagnosis of urological tumors, integrated Chinese and Western medicine treatment, and improvements in surgical techniques; the integrated Chinese and Western medicine prevention and treatment of urinary calculi; and exploration of the mechanisms of action of traditional Chinese medicine in urinary diseases. It undertakes more than ten national- and provincial-/ministerial-level projects and has more than ten invention patents. It has published nearly 200 papers in various academic journals, including more than 40 SCI papers in European Urology, World J Urology, Urology, and other journals with the greatest influence in the field of urology.

The Department of Urology has consistently upheld the spirit of “Great Medical Virtue, the Dawn of Life” and the service philosophy of “Pursuing Perfection · Virtue Throughout the World,” highlighting the departmental features of “minimally invasive and personalized care, with equal emphasis on Chinese and Western medicine.” It remains people-oriented and does everything possible to provide every patient with the most optimized and highest-quality diagnostic and treatment services.

Departmental Diagnostic and Treatment Technology Highlights:

1. Robotic single-port radical cystectomy + orthotopic neobladder——the least traumatic and highest-quality-of-life surgical approach for radical bladder cancer treatment.

2. Robotic single-port radical prostatectomy——the least traumatic surgical approach for radical prostate cancer treatment, with the fastest recovery of urinary continence.

3. Robotic single-port urethra-preserving prostatectomy——the most advanced surgical approach for benign prostatic hyperplasia; continuous bladder irrigation is not required postoperatively, and there are no urethral irritation symptoms.

4. Robotic nephron-sparing partial nephrectomy——using the world's first clamp-free scraping-suction-binding method (CSPB) and the sequential superselective renal segmental artery clamping method to remove renal tumors, preserving renal function to the greatest extent possible.

5. Treatment of benign prostatic hyperplasia with thulium laser, holmium laser, plasma, and other energy platforms——the most comprehensive range of surgical approaches for treating benign prostatic hyperplasia.

6. Mini-tract percutaneous nephrolithotomy (mPCNL) lithotripsy and stone extraction——the surgical method with the least trauma and highest stone-clearance rate.

7. MRI-ultrasound image-fusion, acupuncture-anesthesia-assisted transperineal prostate needle biopsy——a biopsy approach involving little trauma and pain and a high prostate cancer diagnostic rate.

8. Comprehensive integrated Chinese and Western medicine treatment of urological tumors——significantly improving the survival time and quality of life of patients with urological tumors such as prostate cancer, bladder cancer, and renal cancer.

9. Integrated Chinese and Western medicine andrology——with the most complete range of Chinese and Western medicine andrology treatments, including acupuncture, moxibustion patches, Chinese herbal medicine, low-energy shock waves, vacuum negative-pressure suction, three-piece penile prostheses, and others.

10. Traditional Chinese Medicine rapid-recovery urologic surgery——promoting rapid postoperative recovery through traditional Chinese medicine methods such as acupuncture, acupoint massage, and Chinese herbal medicine.

11. Integrated Chinese and Western medicine treatment of urinary calculi——with the most complete range of stone-treatment methods, including acupuncture analgesia, urinary stone-expelling mixture (hospital preparation) to promote stone expulsion, extracorporeal shock wave lithotripsy, and various minimally invasive surgeries.